As healthcare professionals and public health leaders continue expressing concerns about adult vaccination rates post-pandemic, GSK has launched its new COiMMUNITY Initiative to improve adult vaccine uptake. As part of the initiative, GSK...
The Centers for Disease Control and Prevention (CDC) advised older and immunocompromised adults in the United States to get the newly available respiratory syncytial virus (RSV) vaccine. The CDC...
On Thursday, the FDA announced that it would grant GSK a fast track designation for its gonorrhea vaccine. The fast track process expedites the review process for drugs used to treat serious conditions...
At the start of COVID-19 vaccinations, myocarditis rates in Mississippi dropped 14% from pre-vaccination COVID-induced myocarditis rates. The Mississippi-based study was published by a researcher at...
An mRNA vaccine produced by Moderna and Merck reduced the risk of skin cancer metastasis or death by 65%, according to clinical trial results shared at the 2023 session of the American Society of...
Adding to the significant progression of mRNA vaccines in cancer care, Memorial Sloan Kettering Cancer Center (MSKCC) researchers have announced promising results from a phase 1 clinical trial using...
The NIH’s National Institute of Allergy and Infectious Disease (NIAID) Vaccine Research Center (VCR) researchers have begun phase 1 clinical trials on a universal mRNA influenza vaccine. The...
Yesterday, the United States Department of Agriculture (USDA) conditionally licensed an oral vaccine for Borrelia burgdorferi, the bacteria that causes Lyme disease. LymeShield, the product...
Following the WHO Strategic Advisory Group of Experts on Immunization (SAGE) earlier this year, the organization released an article updating its human papillomavirus (HPV) vaccine guidelines after...
Despite valiant efforts by other pharmaceutical companies — namely, Pfizer — GSK has secured its spot in the respiratory syncytial virus (RSV) vaccine market, becoming the first-ever...
On April 18, 2023, the FDA issued an announcement, updating the emergency use authorization (EUA) for the bivalent mRNA COVID-19 vaccines. Attempting to simplify use for healthcare professionals, the...
In a news release published Tuesday, the FDA announced that most individuals who already received a bivalent booster vaccine would not be eligible for another dose. FDA officials said they intend to...
This week federal officials announced the $5 billion successor to Operation Warp Speed, dubbed Project Next Gen. The program will seek to address the growing threat of coronaviruses and the possibility...
On April 3, 2023, the United States HHS released detailed information for a National Cancer Plan. The plan aims to facilitate the Cancer Moonshot initiative. The Biden administration reignited the...
The WHO Strategic Advisory Group of Experts on Immunization (SAGE) announced the results of its March meeting, updating its COVID-19 vaccination guidance. According to the news release, the...
Insufficient sleep has detrimental effects on vaccine efficacy. A recent meta-analysis published in Current Biology determined that less than six hours of sleep per night resulted in a reduced antibody...
In a recent NIH press release, the organization announced a new study published in Nature Communications analyzing the safety and immunogenicity of a new temperature-stable tuberculosis (TB) vaccine....
The Cleveland Clinic recently announced that it would begin enrolling patients for its phase 1b breast cancer vaccine study. The study will focus on cancer-free patients at risk of developing cancer,...
In a 2023 update to the recommended pediatric immunization schedule, the CDC has included recommendations for the COVID-19 vaccine starting at six months. While these guidelines do not force or mandate...
Using data estimates from national pharmacy testing, the CDC analyzed the preliminary efficacy of bivalent mRNA vaccines against multiple COVID variants. The data were collected from December 1, 2022,...
